Clinical Use of Immunohistopathologic Methods for the Diagnosis of Cytomegalovirus Hepatitis in Human Liver Allograft Biopsy Specimens

References

• Pass R F., Stagno S, Britt W J., Alford C A. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J. Infect Dis 1983; 148: 953–61
   Google Scholar
• Schneiderman D J., Arenson D M., Cello J P., Margaretten W, Weber T E. Hepatic disease in patients with the acquired immunodeficiency syndrome (AIDS). Hepatology 1987; 7: 925–30
   PubMed Web of Science ®Google Scholar
• Peterson P K., Balfour H H., Jr., Marker S C., Fryd D S., Howard R J., Simmons R L. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 1980; 59: 283–300
   PubMed Web of Science ®Google Scholar
• Bronsther O, Makowka L, Jaffe R, Demetris A J., Breinig M K., Ho M, et al. Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol 1988; 24: 423–34
   PubMedGoogle Scholar
• Ringdén O. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J. Antimicrob Agents Chemother 1986; 17: 373–86
   Google Scholar
• Ho M. Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient. Transplant Proc 1991; 23(Suppl 1)2–7
   PubMedGoogle Scholar
• Demetris J A., Jaffe R, Starzl T E. A review of adult and pediatric post-transplant liver pathology. Pathol Annu 1987; 22: 347–86
   PubMedGoogle Scholar
• Snover D C., Freese D K., Sharp H L., Bloomer J R., Najarian J S., Ascher N L. Liver allograft rejection: an analysis of the use of biopsy in determining the outcome of rejection. Am J Surg Pathol 1987; 11: 1–10
   PubMed Web of Science ®Google Scholar
• TenNapel C HH, Houthoff H J., The T H. Cytomegalovirus hepatitis in normal and immune-compromised hosts. Liver 1984; 4: 184–94
   PubMedGoogle Scholar
• Masih A S., Linder J, Shaw B W., Jr., Wood R P., Donovan J P., White R, et al. Rapid identification of cytomegalovirus in liver allograft biopsies by in situ hybridization. Am J Surg Pathol 1988; 12: 362–7
   PubMed Web of Science ®Google Scholar
• Naoumov N V., Alexander G JM, Eddleston A LW, Williams R. In situ hybridization in formalin fixed, paraffin wax embedded liver specimens: method for detecting human and viral DNA using biotinylated probes. J Clin Pathol 1988; 41: 793–8
   PubMed Web of Science ®Google Scholar
• Paya C V., Holley K E., Wiesner R H., Balasubramaniam K, Smith T F., Espy M J., et al. Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: role of immunostaining, DNA hybridization and culture of hepatic tissue. Hepatology 1990; 12: 119–26
   PubMedGoogle Scholar
• Sacks S L., Freeman H J. Cytomegalovirus hepatitis: evidence for direct hepatic viral infection using monoclonal antibodies. Gastroenterology 1984; 86: 346–50
   PubMed Web of Science ®Google Scholar
• Starzl T E., Iwatsuki S, Esquivel C O., Todo S, Kam I, Lynch S, et al. Refinements in the surgical technique of liver transplantation. Semin Liver Dis 1985; 5: 349–56
   PubMedGoogle Scholar
• Barkholt L, Ericzon B G., Tollemar J, Malmborg A S., Ehrnst A, Wilczek H, et al. Infections in human liver recipients: different pattern early and late after liver transplantation. Transplant Int 1993; 6: 77–84
   PubMedGoogle Scholar
• Ericzon B G., Eusufzai S, Kubota K, Einarsson K, Angelin B. Characteristics of biliary lipid metabolism after liver transplantation. Hepatology 1990; 12: 1222–8
   PubMedGoogle Scholar
• Williams J W., Peters T G., Vera S R., Britt L W., van Voorst S J., Haggitt R C. Biopsy directed immunosuppression following hepatic transplantation in man. Transplantation 1984; 39: 589
   Google Scholar
• Jenkins J R., Gallik-Karlson C A., Georgi B A., Rohrer R J., Khet-Try U, et al. Safety and utility of a simple technique of liver biopsy following liver transplantation. Transplant Proc 1987; 19: 2480–2
   PubMedGoogle Scholar
• Niedobitek G, Finn T, Herbst H, Gerdes J, Grillner L, Land-Qvist M, et al. Detection of cytomegalovirus by in situ hybridization and immunohistochemistry using new monoclonal antibody CCH2: a comparison of methods. J Clin Pathol 1988; 41: 1005–9
   PubMed Web of Science ®Google Scholar
• Pereira L, Hoffman M, Gallo D, Cremer N. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify crossreactive determinants. Infect Immun 1982; 36: 924–32
   PubMedGoogle Scholar
• Andersson J, Nybom R, Larsson P, Andersson U, Britton S, Ehrnst A. Rapid detection of cytomegalovirus using immune scanning electron microscopy. J Virol Meth 1987; 16: 55–64
   PubMedGoogle Scholar
• Grefte J MM, Van der Giessen M, Van der Gun B TF, Van Son W J., The T. The predominant viral antigen present in peripheral blood leucocytes during an active cytomegalovirus infection is the lower matrix protein pp65. Progress in cytomegalovirus research, M P. Landini. Elsevier Science Publishers, Amsterdam 1991; 233–6, (International Congress Series 978)
   Google Scholar
• Ehrnst A, Barkholt L, Brattstrom C, Czajkowski J, Teodosiu O, Tollemar J, et al. Detection of CMV-matrix pp65 antigen in leucocytes bv immunofluorescence as a marker of CMV disease. J Virol 1993; 39: 118–24
   Google Scholar
• Mocarski E, Pereira L, Michael N. Precise localization of genes on large animal virus genomes. Use of lambda gtll and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci USA 1985; 82: 1266–70
   PubMedGoogle Scholar
• Landini M-P, Michelson S. Human cytomegalovirus proteins. Prog Med Virol 1988; 35: 152–85
   PubMedGoogle Scholar
• Hsu S M., Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
   PubMed Web of Science ®Google Scholar
• Brigati D J., Myerson D, Leary J J., Spalholz B, Travis S Z., Fong C KY, et al. Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridization probes. Virology 1983; 126: 32–50
   PubMed Web of Science ®Google Scholar
• Sundqvist V A., Wahren B. An interchangeable ELISA for cytomegalovirus and antibody. J Virol Meth 1981; 2: 301–12
   PubMed Web of Science ®Google Scholar
• Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. Multi-disciplinary approach to understanding cytomegalovirus disease, S Michelson, S A. Plotkin. Elsevier Science Publishers, Amsterdam 1993; 233–7, (International Congress Series 1032)
   Google Scholar
• Henley K S., Lucey M R., Appelman H D., Baliga P, Brown K A., Burtch G D., et al. Biochemical and histopathological correlation in liver transplant: the first 180 days. Hepatology 1992; 16: 688–93
   PubMedGoogle Scholar
• Alessandro A M., Kalayoglu M, Sollinger H W., Hoffman R M., Reed A, Knechtle S J., et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51: 157–63
   PubMedGoogle Scholar
• Esquivel C O., Jaffe R, Gordon R D., Iwatsuki S, Shaw B W., Jr., Starzl T E. Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis 1985; 5: 369–74
   PubMedGoogle Scholar
• Busuttil R W. Liver transplantation today. Ann Intern Med 1986; 104: 377–89
   PubMedGoogle Scholar
• Awad J, Peters M G., Brunt E, Hanto D W. Herpes viral hepatitis in liver transplant recipients. Clin Transplant 1992; 6: 16–20
   Google Scholar